review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Emily Chew | Q24266614 |
P2093 | author name string | Mary E. Aronow | |
P2860 | cites work | The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 |
{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study | Q37421203 | ||
The impact of fish and shellfish consumption on age-related macular degeneration | Q37489484 | ||
Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). | Q37537304 | ||
Treatment for atrophic macular degeneration | Q37856136 | ||
Dietary fatty acids and the 5-year incidence of age-related maculopathy | Q39761772 | ||
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study | Q41654781 | ||
Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative | Q43881495 | ||
Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
Underwood Memorial LectureHuman Zinc Homeostasis: Good but Not Perfect | Q48570446 | ||
Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. | Q53529956 | ||
Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) | Q63344335 | ||
Age-Specific Prevalence and Causes of Blindness and Visual Impairment in an Older Population | Q64461584 | ||
Oral zinc in macular degeneration | Q68126625 | ||
Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration | Q86897828 | ||
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 | ||
The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study | Q28248143 | ||
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration | Q33613360 | ||
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 | Q33613367 | ||
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial | Q34405938 | ||
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year | Q34582050 | ||
Nutritional supplementation in age-related macular degeneration | Q34619289 | ||
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. | Q34652928 | ||
Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study | Q34657635 | ||
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. | Q34666874 | ||
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. | Q34805968 | ||
VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness | Q35743924 | ||
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study | Q36136223 | ||
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 | Q36257030 | ||
Carotenoid actions and their relation to health and disease | Q36323052 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 186-90 | |
P577 | publication date | 2014-05-01 | |
P1433 | published in | Current Opinion in Ophthalmology | Q15757956 |
P1476 | title | Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions | |
P478 | volume | 25 |
Q36966858 | Absorption, metabolism, and functions of β-cryptoxanthin |
Q90464199 | Central retinal vein occlusion secondary to severe iron-deficiency anaemia resulting from a plant-based diet and menorrhagia: a case presentation |
Q38611218 | Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data |
Q38786743 | Drusen maculopathy: a risk factor for visual deterioration |
Q34518507 | Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration |
Q51209887 | Iron accumulates in the primate choroid of the eye with aging as revealed with synchrotron X-ray fluorescence microscopy. |
Q36173190 | Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes |
Q37229764 | Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance |
Q26824335 | Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development |
Q28555093 | Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo |
Q41961558 | Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration. |
Q48251018 | RPE65 takes on another role in the vertebrate retina |
Q35744184 | The Effect of Zeaxanthin on the Visual Acuity of Zebrafish. |
Q92982650 | The Role of Fish Oil in Inflammatory Eye Diseases |
Q86603541 | [Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014] |
Search more.